ArticleCureus2026
Hepatic Adrenal Rest Tumour (HART) Preoperatively Diagnosed as Hepatocellular Carcinoma in a Patient With Chronic Hepatitis B: Radiological Similarities in Lesions.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic adrenal rest tumours (HARTs) are rare benign lesions arising from ectopic adrenocortical tissue. Their radiological resemblance to hepatocellular carcinoma (HCC) presents a significant diagnostic challenge. We report a case of HART in a woman in her 60s with chronic hepatitis B (CHB) without cirrhosis who underwent surgical resection following a preoperative diagnosis of HCC. The patient, who was of Filipino descent, was being treated with entecavir and underwent a routine six-monthly HCC surveillance, during which a lesion of concern was identified on ultrasound. Liver synthetic function and serum transaminases were within normal limits, hepatitis B viral load was undetectable, and serum alpha-fetoprotein was normal. MRI demonstrated a 14-mm fat-containing lesion in segment VI according to the Couinaud classification, exhibiting homogeneous arterial phase hyperenhancement and portal venous washout, findings considered radiologically consistent with HCC. Following multidisciplinary review, she underwent laparoscopic hepatectomy. Histopathological examination revealed a well-circumscribed lesion composed of compact nests of uniform cells with regular round nuclei and finely vacuolated clear cytoplasm. Immunohistochemistry demonstrated positivity for inhibin and Melan-A, with negative staining for PAX8, HepPar-1, AE1/AE3, S100, HMB45, synaptophysin, and chromogranin, establishing the diagnosis of HART. This case highlights the difficulty in distinguishing HART from HCC based on imaging alone, particularly in patients with established HCC risk factors. Recognition of HART as a potential differential diagnosis for hypervascular hepatic lesions may support more informed multidisciplinary evaluation and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.